GSK to stop paying doctors to make speeches
1st January 2014
GlaxoSmithKline (GSK) is making major changes to its incentive schemes following a damaging corruption scandal in China.
The pharmaceuticals firm will stop paying doctors to promote its products through speaking engagements. Members of its sales force will also no longer have individual sales targets. Earlier this year, Chinese police said GSK had transferred 3bn yuan ($489m; £321m) to travel agencies and consultancies to help bribe doctors.